Literature DB >> 7931653

Myocardial imaging with technetium-99m-tetrofosmin: comparison of one-day and two-day protocols.

S H Braat1, B Leclercq, R Itti, A Lahiri, B Sridhara, P Rigo.   

Abstract

UNLABELLED: There is no evidence of myocardial redistribution after tetrofosmin injection, therefore, two separate injections are needed to differentiate scar from ischemia with this tracer. The injections can be given on the same day (one-day protocol) or on separate days (two-day protocol). As part of a Phase II clinical study, a one-day protocol was compared with a two-day protocol.
METHODS: Fifty-five patients with suspected coronary artery disease were studied according to the following protocol: on the first day at rest, anterior, left lateral, left anterior oblique 40 degrees and 70 degrees images were acquired 30 min after injection of 8 mCi of tetrofosmin for 5 min each. Two days later, exercise and rest images were acquired on the same day. At peak exercise, 8 mCi of tetrofosmin were injected and 30 min later the same four standard planar images were recorded as on Day one. Four hours after the exercise injection, 24 mCi of tetrofosmin were injected at rest and imaging was repeated 30 min later. Qualitative comparisons between the one- and two-day protocols were performed in 50 patients in whom all data were available following blinded evaluation of images by three readers.
RESULTS: All three readers reported identical results for the 26 patients. A difference in extent or location between the observers was found in seven patients, differences between normal and abnormal in eight patients, while discrepancies between ischemia and necrosis were noted in four patients. In five patients, an ischemic area was found according to the one-day protocol, but according to the data of the two-day protocol, this area was judged to be necrotic. One observer reported the opposite in one patient. These discrepancies between the reversibility of defects were restricted to the inferior wall. Comparison with 201Tl data showed no systematic pattern of variation.
CONCLUSION: Tetrofosmin can be used in a one-day protocol. However, in planar imaging, the inferior wall should be reported with caution.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7931653

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  Stress protocols and tracers.

Authors:  Milena J Henzlova; Manuel D Cerqueira; John J Mahmarian; Siu-Sun Yao
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

2.  The effects of solid food in prevention of intestinal activity in Tc-99m tetrofosmin myocardial perfusion scintigraphy.

Authors:  Adil Boz; Firat Gungor; Binnur Karayalçin; Akin Yildiz
Journal:  J Nucl Cardiol       Date:  2003 Mar-Apr       Impact factor: 5.952

3.  What is the optimal activity ratio for same-day myocardial perfusion SPECT?

Authors:  Ian S Armstrong
Journal:  J Nucl Cardiol       Date:  2020-10-20       Impact factor: 5.952

4.  Tc-99m tetrofosmin myocardial distribution 4 hours post injection.

Authors:  M Pillay; P H Cox; D H Schönfeld; S Mathews
Journal:  Int J Card Imaging       Date:  1996-06

5.  Technetium-99m tetrofosmin rest/stress myocardial SPET with a same-day 2-hour protocol: comparison with coronary angiography. A Spanish-Portuguese multicentre clinical trial.

Authors:  R Montz; M J Perez-Castejón; J A Jurado; J Martín-Comín; E Esplugues; L Salgado; A Ventosa; G Cantinho; E P Sá; A T Fonseca; M R Vieira
Journal:  Eur J Nucl Med       Date:  1996-06

6.  Tc-99m tetrofosmin myocardial SPECT perfusion imaging: comparison of rest-stress and stress-rest protocols.

Authors:  M M Boomsma; M G Niemeyer; E E van der Wall; B L van Eck-Smit; A H Zwinderman; J H Boomsma; E K Pauwels
Journal:  Int J Card Imaging       Date:  1998-04

7.  Quantitative estimation of myocardial salvage after primary percutaneous transluminal coronary angioplasty in patients with angiographic no reflow.

Authors:  Seishi Nakamura; Kazuya Takehana; Tetsuro Sugiura; Kengo Hatada; Shinichi Hamada; Junko Asada; Reisuke Yuyama; Jun Mimura; Yusuke Imuro; Hirohiko Kurihara; Masayoshi Fukui; Masato Baden; Toshiji Iwasaka
Journal:  Eur J Nucl Med Mol Imaging       Date:  2002-12-19       Impact factor: 9.236

8.  Comparison of ⁹⁹mTc-N-DBODC5 and ⁹⁹mTc-MIBI of myocardial perfusion imaging for diagnosis of coronary artery disease.

Authors:  Haiyan Ma; Sijin Li; Zhifang Wu; Jianzhong Liu; Haiyan Liu; Xiaoshan Guo
Journal:  Biomed Res Int       Date:  2013-06-11       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.